Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01524978
Title A Study of Zelboraf (Vemurafenib) in Patients With BRAF V600 Mutation-Positive Cancers
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Hoffmann-La Roche
Indications

Advanced Solid Tumor

multiple myeloma

Therapies

Vemurafenib

Cetuximab

Age Groups: adult | senior
Covered Countries USA | FRA | ESP | DEU

Additional content available in CKB BOOST